Featured Posts
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
Search Posts
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. HURRICANE KATRINA Public health officials predict a surge in disease-carrying mosquito populations in standing water along…
Op-Eds
Big Tobacco Market Share Is Big Concern for States
In defending its settlement with Big Tobacco, the National Association of Attorneys General (NAAG) argues that “the states are not 'partners with the…
News Release
Katrina’s Aftermath: What Will it Take to Rebuild ‘The Big Easy’?
Washington, D.C., September 7, 2005— As the relief effort continues in <?xml:namespace prefix = st1 ns = “urn:schemas-microsoft-com:office:smarttags” />New Orleans, questions about how…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. ENERGY Lost refining capacity in the wake of Hurricane Katrina contributes to higher gas prices and…
Op-Eds
Politics Kills the Thriller
The Constant Gardener, Focus Features' new thriller, plays like the grim, dour counterpart to this year's earlier globetrotting adventure film,…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. NATURAL DISASTER Congress moves to provide $10.5 billion in aid to victims on Hurricane…